Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Price-to-book ratio
5Y CAGR
-18.0%/yr
Long-term compound
Percentile
P54
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.93 | +545.7% |
| 2024 | 0.45 | +31.2% |
| 2023 | 0.35 | +108.0% |
| 2022 | -4.34 | -156.6% |
| 2021 | 7.68 | -2.8% |
| 2020 | 7.90 | -46.2% |
| 2019 | 14.68 | +173.2% |
| 2018 | 5.37 | +154.0% |
| 2017 | 2.11 | -94.4% |
| 2016 | 37.54 | - |